Functional endoscopic sinus surgery (FESS) was introduced to the US in 1984. FESS advocates a systematic approach to the surgical treatment of diseases of the nose and paranasal sinuses.
GSK said that both the Anchor-1 and Anchor-2 trials met their co-primary endpoints of a change from baseline in total endoscopic nasal polyp score after 52 weeks, as well as a change in mean nasal ...
We are pleased to have fully enrolled the second of our two pivotal trials of LYR-210 in CRS patients, and our team is moving forward expeditiously to report the results in Q2 of next year,” said ...
Some essential oils may clear up nasal passages and relieve sinus pressure and other congestion symptoms. Sinus congestion is uncomfortable to say the least. It may make it difficult for you to ...
LONDON, UK I October 14, 2024 I GSK plc (LSE/NYSE: GSK) today announced positive headline results from the phase III clinical trials ANCHOR-1 and ANCHOR-2, ...